Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Supplement 1 , Pages S31-S45, December 2006

What is the optimal strategy for postoperative treatment with aromatase inhibitors in the adjuvant setting?

  • Fritz Jänicke (Professor; Chairman and Head of the Department of Gynecology)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +49 40 4 28 03 3510; Fax: +49 40 4 28 03 4355.
  • Paolo Pronzato (Professor)

      Affiliations

    • Tel.: +39 0187 533 688; Fax: +39 0187 533 688.
    • Present Address: Department of Oncology, Istituto Nazionale per la Ricerca sul Cancro, largo R.Benzi 10, 10632 Genova. Tel.: +39 010 5600668; Fax +39 010 5600850.

Center of Gynecology, Obstetrics and Pediatrics, University Hospital Hamburg-Eppendorf, Martinistr 52, Hamburg D-20246, Germany

Department of Oncology, Ospedale Sant'Andrea, Via V Veneto, La Spezia, 19100, Italy

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S1521-690X(06)00080-7

doi:10.1016/j.beem.2006.10.001

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 20, Supplement 1 , Pages S31-S45, December 2006

Article Tools

* Image Usage & Resolution